Table 2.
Distribution of clinical characteristics of tuberculosis cases according to multimorbidity status in Brazil, 2011
|
Characteristics |
TB |
TB – MM |
p value* |
|
|---|---|---|---|---|
| n (%) | n (%) | |||
| Type of treatment (39,879) |
New case |
32,478 (98.9) |
373 (1.1) |
0.244 |
| |
Relapse |
2,232 (98.5) |
33 (1.5) |
|
| |
Return after abandonment |
2,514 (99.2) |
21 (0.8) |
|
| |
Unknown |
84 (100) |
0 (0) |
|
| |
Transferred |
2,117 (98.7) |
27 (1.3) |
|
| TB form (39, 865) |
Pulmonary |
33,213 (98.9) |
372 (1.1) |
0.073 |
| |
Extrapulmonary |
4,970 (98.6) |
72 (1.4) |
|
| |
Pulmonary + extrapulmonary |
1,228 (99.2) |
10 (0.8) |
|
| Tuberculin skin test (6,532) |
Negative |
1,868 (98.6) |
27 (1.4) |
0.003 |
| |
Positive |
4,606 (99.3) |
31 (0.7) |
|
| X-ray suspicious (33,297) |
No |
2,220 (98.6) |
32 (1.4) |
0.218 |
| |
Yes |
30,693 (98.9) |
352 (1.1) |
|
| Initialbacilloscopy (32,804) |
Negative |
8,721 (98.9) |
101 (1,1) |
0.964 |
| |
Positive |
23,706 (98.8) |
276 (1.2) |
|
| Culture (9,667) |
Negative |
3,389 (99.1) |
31 (0.9) |
0.207 |
| |
Positive |
6,173 (98.8) |
74 (1.2) |
|
| Histopathologic examination (4,298) |
Not suggestive |
260 (98.9) |
3 (1.1) |
0.084 |
| |
AFB positive |
1,787 (98.9) |
19 (1.1) |
|
| |
Suggestive of TB |
2,187 (98.1) |
42 (1.9) |
|
| DOTS indication (37,432) |
No |
15,522 (98.8) |
187 (1.2) |
0.348 |
| |
Yes |
21,487 (98.9) |
236 (1.1) |
|
| Under DOTS (33,504) |
No |
14,838 (98.8) |
178 (1.2) |
0.347 |
| |
Yes |
18,289 (98.9) |
199 (1.1) |
|
| Occupational disease (24,077) |
No |
23,177 (98.9) |
281 (1,1) |
0.831 |
| |
Yes |
611 (98.7) |
8 (1.3) |
|
| Treatment outcome (39,879) |
Cured |
28,625 (98.9) |
302 (1.1) |
<0.001 |
| |
Abandonment |
5,490 (99.5) |
29 (0.5) |
|
| |
Death from TB |
2,243 (98.1) |
44 (1.9) |
|
| |
Death from other cause |
2,828 (97.4) |
76 (2.6) |
|
| MDR TB | 239 (98.8) | 3 (1.2) | ||
AFB Acid fast bacilli, DOTS Directly observed treatment short, MDR TB Multidrug resistant tuberculosis, MM Multimorbidity, TB Tuberculosis.
*Pearson chi-square test.